Hematology

Hydroxyurea was not associated with increased infection risk in children with sickle cell anaemia, with rates declining through treatment phases.

Venetoclax-based therapy enabled many children with relapsed acute leukaemia to proceed to stem cell transplantation.

A Myeloma-XI analysis identified clinical, tumour and inherited genetic factors associated with arterial thromboembolism risk in multiple myeloma.

Earlier transplantation after high-risk features emerge may improve survival in Shwachman-Diamond syndrome.

A multicentre study found associations between transplant immunosuppression regimens and rates of sinonasal disease, allergic rhinitis and acute invasive fungal sinusitis.

Anaemia-supporting therapy may help patients with myelofibrosis maintain ruxolitinib dosing and clinical responses.

A CD38-CD3 bispecific antibody showed early activity in heavily pretreated AML and T-ALL.

An early discharge clinic cut hospital stays by almost 40% for selected patients with haematological malignancies.